Drug class
First-generation phenothiazine antihistamine; histamine H1 receptor antagonist
Mechanism of action
Antagonises peripheral histamine H1 receptors and reduces histamine-mediated allergic symptoms. It has sedative and anticholinergic properties; receptor selectivity and risk profile vary by dose and formulation.
General use cases
- Symptomatic treatment of allergic rhinitis and urticaria in countries where mequitazine products are authorised; current availability and age restrictions are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
